Baltimore City's Mass Notification System! CivicRec has migrated to a Public Single Sign-On. Learn how to access CivicRec accounts here. Check out our 2024 Year In Review! Click to …

Jan 15, 2023 · The human breast cancer resistance protein (BCRP, gene symbol ABCG2) is an ATP-binding cassette (ABC) efflux transporter. It was so named because it was initially cloned from a multidrug-resistant breast cancer cell line where it was found to confer ...

TEAM MANAGERS ONLY – once paid, click the “Roster” button to enter your team into the standings and begin forming your roster. Once entered, the system will send an automated email to your players asking them to join your team. This process also enables your players to receive weather notifications.

The ATP-binding cassette transporter G2 (ABCG2; also known as breast cancer resistance protein, BCRP) has been suggested to be involved in clinical multidrug resistance (MDR) in cancer like other ABC transporters such as ABCB1 (P-glycoprotein).

Since cloning of the ATP-binding cassette (ABC) family member breast cancer resistance protein (BCRP/ABCG2) and its characterization as a multidrug resistance efflux transporter in 1998, BCRP has been the subject of more than two thousand scholarly articles.

Breast cancer resistance protein (BCRP) is a half-molecule ATP-binding cassette transporter that pumps out various anticancer agents such as 7-ethyl-10-hydroxycamptothecin, topotecan and mitoxantrone.

The human breast cancer resistance protein (BCRP/ABCG2) is the second member of the G subfamily of the large ATP-binding cassette (ABC) transporter superfamily. BCRP was initially discovered in multidrug resistant breast cancer cell lines where it confers resistance to chemotherapeutic agents such a …

Jan 1, 2022 · BCRP is a membrane-bound transporter that can bind substrate molecules and transfer them across that lipid bilayer. When positioned at a cell’s external membrane, BCRP transport is directed toward the extracellular fluid, which decreases the amount of BCRP substrates within that cell.

Feb 1, 2023 · Breast cancer resistance protein (BCRP) is a clinically relevant ATP-binding cassette (ABC) transporter for drug disposition. Inhibition of BCRP increases the plasma concentrations of BCRP substrate drugs, which potentially could lead to adverse drug reactions.

Breast Cancer Resistance Protein (BCRP) is an efflux transporter responsible for causing multidrug resistance (MDR). It is known to expel many potent antineoplastic drugs, owing to its efflux function.